[go: up one dir, main page]

EA200500500A1 - Новые антимикобактериальные соединения - Google Patents

Новые антимикобактериальные соединения

Info

Publication number
EA200500500A1
EA200500500A1 EA200500500A EA200500500A EA200500500A1 EA 200500500 A1 EA200500500 A1 EA 200500500A1 EA 200500500 A EA200500500 A EA 200500500A EA 200500500 A EA200500500 A EA 200500500A EA 200500500 A1 EA200500500 A1 EA 200500500A1
Authority
EA
Eurasian Patent Office
Prior art keywords
tuberculosis
formula
new
compounds
resistant
Prior art date
Application number
EA200500500A
Other languages
English (en)
Other versions
EA012461B1 (ru
Inventor
Судершан Кумар Арора
Неелима Синха
Санджай Джаин
Рам Шанкар Упадхайайа
Гурхари Джана
Шанкар Аджай
Ракеш Кумар Синха
Original Assignee
Люпин Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Люпин Лимитед filed Critical Люпин Лимитед
Publication of EA200500500A1 publication Critical patent/EA200500500A1/ru
Publication of EA012461B1 publication Critical patent/EA012461B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Новые производные пиррола формулы (I)и их фармацевтически приемлемые кислотно-аддитивные соли, обладающие лучшей противомикобактериальной активностью по отношению как к лекарственно чувствительным, так и лекарственно резистентным штаммам Mycobacterium tuberculosis, и являющиеся менее токсичными по сравнению с известными соединениями. Применение новых соединений формулы (I) для лечения латентного туберкулеза, включая туберкулез, вызываемый полирезистентными микобактериями. Способы получения новых соединений, фармацевтических композиций, содержащих новые соединения, и способы лечения туберкулеза, вызываемого полирезистентными туберкулезными микобактериями, путем введения соединений формулы (I).Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200500500A 2002-09-20 2002-09-20 Соединения, обладающие антимикобактериальной активностью EA012461B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2002/000189 WO2004026828A1 (en) 2002-09-20 2002-09-20 Pyrrole derivatives as antimycobacterial compounds

Publications (2)

Publication Number Publication Date
EA200500500A1 true EA200500500A1 (ru) 2006-02-24
EA012461B1 EA012461B1 (ru) 2009-10-30

Family

ID=32012142

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500500A EA012461B1 (ru) 2002-09-20 2002-09-20 Соединения, обладающие антимикобактериальной активностью

Country Status (19)

Country Link
US (2) US7691837B2 (ru)
EP (2) EP1546097A1 (ru)
JP (1) JP2006503837A (ru)
CN (1) CN1668584A (ru)
AP (1) AP1979A (ru)
AU (1) AU2002343200B2 (ru)
BR (1) BR0215873A (ru)
CA (1) CA2499701A1 (ru)
EA (1) EA012461B1 (ru)
HR (1) HRP20050347A2 (ru)
HU (1) HUP0500598A2 (ru)
IS (1) IS7795A (ru)
MX (1) MXPA05003022A (ru)
NO (1) NO20051901L (ru)
NZ (1) NZ539449A (ru)
RS (1) RS20050231A (ru)
TN (1) TNSN05080A1 (ru)
UA (1) UA81640C2 (ru)
WO (1) WO2004026828A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491721B2 (en) * 2004-05-12 2009-02-17 Lupin Limited Antimycobacterial pharmaceutical composition
RU2424240C2 (ru) * 2005-02-18 2011-07-20 Астразенека Аб Антибактериальные производные пиперидина
ITRM20050094A1 (it) 2005-03-04 2006-09-05 Univ Siena Derivati del 1-(1,5-di(4-clorofenil)-2metil-1h-3-pirroli)metil)-4-metilpiperazina (bm 212), procedimento per la loro produzione e uso di essi come antitubercolari.
WO2006109323A1 (en) * 2005-04-11 2006-10-19 Lupin Limited Preparation of [2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)] pyrrole derivatives
CN101190894A (zh) * 2006-11-23 2008-06-04 中国人民解放军军事医学科学院毒物药物研究所 脂肪酸合成酶抑制剂及其制药用途
EP2311457A1 (en) 2009-10-19 2011-04-20 Forschungszentrum Borstel Pharmaceutical compositions for treating infections with drug resistant mycobacteria
HUP1000033A2 (en) * 2010-01-21 2011-07-28 Uratim Kft Piperazine derivatives useful against mycobacteriums
WO2011117708A1 (en) * 2010-03-22 2011-09-29 Council Of Scientific & Industrial Research Antituberculosis compositions of byttneria species
KR100998556B1 (ko) 2010-04-08 2010-12-07 강원대학교산학협력단 신규한 다치환 피롤 유도체와 이의 제조방법
CN103122370B (zh) * 2011-11-21 2014-06-18 华中农业大学 一种三嗪类化合物作为抗结核分枝杆菌抑制剂的应用
CN104428261B (zh) 2012-07-13 2018-09-11 康宁股份有限公司 制备层压玻璃片的方法和设备
US9657037B2 (en) 2013-06-03 2017-05-23 Council Of Scientific And Industrial Research Pyrrole compounds with silicon incorporation
KR102126576B1 (ko) 2018-09-19 2020-06-24 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
RU2767542C1 (ru) * 2021-05-24 2022-03-17 Федеральное государственное автономное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" (ПГНИУ) Противотуберкулезное средство на основе 4-((гет)ароил)-3- гидрокси-1-(2-гидроксифенил)-5-(фенилтио)-1,5-дигидро-2Н-пиррол-2-онов

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2986564A (en) * 1959-02-20 1961-05-30 Rips Richard Pyrrole compounds
US3246010A (en) * 1963-06-10 1966-04-12 Parke Davis & Co 1, 5-diaryl-2-pyrrole propanols and ethers
US3168531A (en) * 1963-06-12 1965-02-02 Parke Davis & Co 1-aryl-5-(p-lower alkoxyphenyl)-pyrrole-2-propionic acid compounds
US3168532A (en) * 1963-06-12 1965-02-02 Parke Davis & Co 1, 5-diarylpyrrole-2-propionic acid compounds
GB1263940A (en) 1968-08-02 1972-02-16 Innothera Lab Sa 0-phenyl-pyrroles

Also Published As

Publication number Publication date
EP1857442A3 (en) 2008-02-06
NZ539449A (en) 2007-08-31
NO20051901L (no) 2005-04-19
MXPA05003022A (es) 2005-05-27
HRP20050347A2 (en) 2006-03-31
AU2002343200B2 (en) 2009-08-13
UA81640C2 (ru) 2008-01-25
US20050107370A1 (en) 2005-05-19
EP1857442A2 (en) 2007-11-21
AP2005003277A0 (en) 2005-06-30
AU2002343200A1 (en) 2004-04-08
EP1546097A1 (en) 2005-06-29
CA2499701A1 (en) 2004-04-01
US20080242676A1 (en) 2008-10-02
JP2006503837A (ja) 2006-02-02
WO2004026828A1 (en) 2004-04-01
BR0215873A (pt) 2005-07-12
EA012461B1 (ru) 2009-10-30
RS20050231A (en) 2007-06-04
IS7795A (is) 2005-04-11
US7763602B2 (en) 2010-07-27
CN1668584A (zh) 2005-09-14
TNSN05080A1 (en) 2007-05-14
US7691837B2 (en) 2010-04-06
HUP0500598A2 (en) 2006-02-28
AP1979A (en) 2009-03-20

Similar Documents

Publication Publication Date Title
EA200500257A1 (ru) Производные хинолина и их применение в качестве микобактериальных ингибиторов
EA200500500A1 (ru) Новые антимикобактериальные соединения
Makarov et al. The 8-pyrrole-benzothiazinones are noncovalent inhibitors of DprE1 from Mycobacterium tuberculosis
EA200602260A1 (ru) Применение замещенных хинолиновых производных для лечения заболеваний, вызываемых микобактериями, резистентными к лекарственным средствам
ID27531A (id) Penggunaan senyawa untuk peningkatan aktivitas piruvat dehidrogenase
EA200601364A1 (ru) Производные хинолина и их применение в качестве ингибиторов микобактерий
EA200700099A1 (ru) Производные пиридина
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
TW200607807A (en) Macrocyclic beta-secretase inhibitors
EA200800455A1 (ru) Антибактериальные производные хинолина
NO20076425L (no) Fremgangsmater for behandling av drug-resistent cancer
Asif A review of antimycobacterial drugs in development
WO2008057802A3 (en) Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
EA200500985A1 (ru) Твердая лекарственная форма для перорального применения
BRPI0617655A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica
EA200401111A1 (ru) Биполярные соли транс-каротиноидов и их применение
EA200400086A1 (ru) Новые производные оксазолидинонов в качестве антибактериальных агентов
BR112017017211A2 (pt) composto, composição, sal farmaceuticamente aceitável de um composto, combinação, formulação farmacêutica, métodos para matar uma micobactéria e/ou inibir a replicação de micobactérias que causam doença em um animal, para tratamento de uma infecção micobacteriana em um animal e para tratamento de uma doença resultante de uma infecção por micobactéria de um mamífero, e, uso de um composto.
EA200500882A1 (ru) N-арилсульфонил-3-аминоалкоксииндолы
Kamal et al. Efforts towards the development of new antitubercular agents: potential for thiolactomycin based compounds
ZA202203107B (en) Azaindole carboxamide compounds for the treatment of mycobacterial infections
ECSP066965A (es) Una composicion farmacéutica antibacterial
Wani et al. Targeting the cytochrome bc 1 complex for drug development in M. tuberculosis

Legal Events

Date Code Title Description
TK4A Corrections in published eurasian patents
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU